A technique was described which used sister chromatid exchanges (SCEs) in human peripheral blood lymphocyte cultures to assess the genotoxic potential of vapors. The compounds tested were methyl- bromide (74839), ethylene-oxide (75218), propylene-oxide (75569), and diesel exhaust. Heparinized human whole blood was obtained from healthy nonsmokers. Whole blood was cultured under standard conditions, with the addition of phytohemagglutinin to stimulate lymphocyte division. After 22 to 26 hours, cultures were exposed to 4.3 percent methyl-bromide (MB), 4.0 percent ethylene-oxide (EO), 2.5 percent propylene-oxide (PO), or direct diesel exhaust. The amount of chemical to which each culture was exposed was achieved by varying the exposure time because it was not possible to adjust chemical concentrations. The number of SCEs were counted, and the data were subjected to square root transformation. MB increased SCE frequency from 9.90 to 16.84 per cell. EO produced increases in SCEs from 10.00 to 25.76 and 9.00 to 26.28 after 10 and 30 second exposures, respectively. PO increased SCEs from 8.74 to 22.74 per cell. Cultures from two donors showed a small but statistically significant increase in SCEs when exposed to diesel emissions, while cultures from two other donors did not. This was unexpected, as the mutagenicity of diesel emissions has been well documented in other systems. The authors suggest this may be due to different individual sensitivities. The authors conclude that this system is useful for detecting volatile genotoxic agents and may have application for monitoring of workplaces where airborne genotoxic agents may exist.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.